1) Tumor-infiltrating lymph nodes
肿瘤浸润淋巴结
2) tumor-infiltrating lymphocytes
肿瘤浸润淋巴细胞
1.
To investigate the mechanisms of hepatic cancer cells inducing apoptosis of tumor-infiltrating lymphocytes (TILs) in vitro, hepatic cancer cells were co-cultured with TILs in different effector-taget ratio.
为了探讨肝癌细胞反击肿瘤浸润淋巴细胞(TIL)的机制,在体外进行肝癌细胞和TIL混合培养后,检测两种细胞FasL、Fas、caspase-8基因的表达情况,以及肿瘤细胞反击时TIL凋亡比例的变化。
2.
Objective To study the expression and significance of CD8~+CD28~+ in gastric carcinoma tumor-infiltrating lymphocytes (TIL) to approach the causes which results in TIL function limits.
目的通过研究CD8~+CD28~+在胃癌肿瘤浸润淋巴细胞(TIL)上的表达及其与肿瘤生物学行为的关系和意义,探讨TIL功能受抑制的原因。
3) tumor-infiltrating lymphocyte
肿瘤浸润淋巴细胞
1.
Objective: To investigate the optimal efficient ratio of efficacy to target (E/T) and the anti-tumor activity of tumor-infiltrating lymphocytes(TILs) and the mouse s splenocyte lymphocytes stimulated by dendritic cells(DCs) on H22 cells in vitro.
目的:探讨树突状细胞(DC)激活肿瘤浸润淋巴细胞(TIL)和小鼠脾淋巴细胞(小鼠脾LC)的最佳效靶比并观察被有效激活的TIL和小鼠脾LC等对小鼠H22肝癌细胞的体外杀伤作用。
2.
T-lymphocyte subsets and the phenotypes of dendritic cells in tumor-infiltrating lymphocytes (TIL) were detected by flow cytometry (FCM).
方法:用LBP给H22荷瘤小鼠灌胃,连续2周后,测定肿瘤重量,采用流式细胞术检查肿瘤浸润淋巴细胞(tumor-infiltratinglymphocyte,T1L)中T淋巴细胞亚群和DCs的数量,以及协同刺激分子CD80(B7-1)表达的变化。
3.
Objective To determine whether human adenocarcinomas FasL expression is associated with increased apoptotic induction in tumor-infiltrating lymphocyte (TIL) and to provide evidence to support the Fas counterattack theory as a mechanism of immune escape in cancer.
目的 通过对人体肿瘤标本的连续切片 ,测定同一区域肿瘤周边病灶中淋巴细胞上的FasL和肿瘤浸润淋巴细胞凋亡的关系 ,探讨肿瘤免疫逃避的机制。
4) Tumor infiltrating lymphocyte
肿瘤浸润淋巴细胞
1.
Objective: To investigate the activities of tumor infiltrating lymphocytes(TILs) stimulated by dendritic cells(DCs) on mouse breast cancer cells in vitro.
目的:探讨致敏的树突状细胞(DC)激活的肿瘤浸润淋巴细胞(TIL)体外抗小鼠乳腺癌活性。
5) Tumor infiltrating lymphocyte
肿瘤浸润性淋巴细胞
1.
Compared with LAK (lymphokine activated killer cells), TIL (tumor infiltrating lymphocyte) has faster proliferation, higher immune activity and stronger killer activity to tumor cells, especially combined with chemotherapy and traditional Chinesemedicine.
肿瘤浸润性淋巴细胞 (tumorinfiltratinglymphocyte,TIL)增殖速度快、免疫活性强 ,比淋巴因子激活的杀伤细胞 (lymphokineactivatedkillercells,LAK)具有更强的特异杀瘤活性 ,与化学治疗及中医中药联用疗效更
补充资料：肿瘤-转移-淋巴结分类
肿瘤-转移-淋巴结分类
tumor-metastasis-node classification,TNM
又称TNM分类。国际性恶性肿瘤的分类法，适用于临床。在治疗前，以临床表现、X线、内镜、手术探查及病理组织学等资料，作为分类的基础。T代表原发瘤。Tis指原位癌。Tx指未发现原发肿瘤。T1、T2、T3、T4表示原发瘤大小和浸润范围。Tx指原发肿瘤大小不能确定。N代表区域淋巴结转移。N0指无区域淋巴结累及。N1、N2、N3表示区域淋巴结转移由少到多和累及范围；N4指相邻区域淋巴结受累。Nx指不能估计区域淋巴结是否累及。M表示远处转移。M0指无远处转移。M1指有远处转移。Mx表示不能肯定有远处转移。TNM分类有助于临床制定治疗计划、估计预后及评价治疗效果。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条